# Mike Dendy

> Mike Dendy is the founder and former CEO of AMPS and the co-founder and CEO of CarynHealth. His career includes founding Health Partners Services, leading HPS Paradigm Administrators through its 2004 sale, overseeing AMPS during its 2017 recapitalization, and serving on Marpai’s board from November 2023 to May 2024.

- **Role:** Co-Founder and CEO at CarynHealth
- **Organizations:** AMPS, CarynHealth, Health Partners Services, HPS Paradigm Administrators, Marpai (former director), Georgia State University Robinson College of Business (advisory board)
- **Education:** Bachelor’s degrees in Journalism and Psychology, University of Georgia, MBA and MHA, Georgia State University, Executive education, including business and professional negotiations programs; not a degree, Harvard University
- **Known for:** Built early HPS consulting revenue to $600,000 annually., HPS Paradigm reported average annual fee income growth of 50% and EBITDA margins above 22% during his CEO tenure., Oversaw AMPS through its May 2017 recapitalization while the management team remained in place.

## Career timeline

- **1992-1997** — Founded and managed Health Partners Services, growing annual consulting revenues to $600,000.
- **1997-2004** — Chairman and CEO of HPS Paradigm Administrators; the business was sold in 2004.
- **2005** — A contemporaneous AMPS biography dates the start of his AMPS tenure to 2005.
- **2017** — Led AMPS as CEO and president during a recapitalization led by Cimarron, with RAF Industries and Leavitt Equity Partners.
- **2018** — CarynHealth was founded; its current biography identifies Dendy as co-founder and CEO.
- **2023-11** — Appointed to Marpai’s board on November 6.
- **2024-05** — Resigned from Marpai’s board effective May 12; the company disclosed no disagreement.
- **2024-09** — Appeared on The Roadmap with Lee Heisman to discuss company building, exits and private equity.

## Achievements

- Built early HPS consulting revenue to $600,000 annually.
- HPS Paradigm reported average annual fee income growth of 50% and EBITDA margins above 22% during his CEO tenure.
- Oversaw AMPS through its May 2017 recapitalization while the management team remained in place.
- CarynHealth reports annual revenue above $40 million under its current leadership.

## Latest updates

- **2024-09** — Appeared on ASBN’s The Roadmap discussing his business exits and his approach to CarynHealth.
- **2024-05** — Resigned from Marpai’s board, effective May 12.

## Links

- LinkedIn: https://www.linkedin.com/in/mikedendy

---

Profile page: https://yespress.io/mike-dendy
Published by YesPress — https://yespress.io
Last updated: 2026-10-26